1. Home
  2. RA vs VALN Comparison

RA vs VALN Comparison

Compare RA & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Real Assets Income Fund Inc.

RA

Brookfield Real Assets Income Fund Inc.

HOLD

Current Price

$13.12

Market Cap

705.0M

Sector

Finance

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$6.09

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RA
VALN
Founded
N/A
2012
Country
United States
France
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
705.0M
536.9M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
RA
VALN
Price
$13.12
$6.09
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$16.00
AVG Volume (30 Days)
139.9K
137.7K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.46
$5.43
52 Week High
$13.59
$12.25

Technical Indicators

Market Signals
Indicator
RA
VALN
Relative Strength Index (RSI) 56.30 28.82
Support Level $12.87 $5.88
Resistance Level $13.30 $6.73
Average True Range (ATR) 0.15 0.28
MACD 0.05 0.04
Stochastic Oscillator 86.57 29.42

Price Performance

Historical Comparison
RA
VALN

About RA Brookfield Real Assets Income Fund Inc.

Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. The investment objective of the Fund is to seek high total return, through high current income and secondarily, through growth of capital. The Fund seeks to achieve its investment objective by investing in the real asset class, which includes the following: Real Estate Securities, Infrastructure Securities, and Natural Resources Securities. The Fund operates in a single operating segment.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: